The bill's provisions specifically address coverage modifications based on medical necessity. If a treating physician certifies that a drug is medically necessary for a subscriber, the insurer must maintain coverage for that drug for the remainder of the policy year without increased costs or restrictions. This authorizes physicians to play a crucial role in ensuring their patients can access needed medications without unnecessary barriers.
Summary
House Bill 1543 aims to enhance the transparency of prescription drug coverage in Florida by mandating health insurers to notify current and prospective insureds about any formulary changes at least 60 days prior to their implementation. This notification must include details about specific drugs affected and how it impacts coverage. Additionally, insurers are required to inform the treating physicians of these changes, ensuring that all parties are aware of the implications for patient care and medication access.
Contention
While there is a shared goal among supporters to improve patient access to necessary medications, the bill has generated discussions about the potential burden on insurers and the complexity of compliance with the new reporting requirements. Critics express concern over the administrative implications and whether the rules may unintentionally limit flexibility in formulary management, which is often needed to account for market dynamics and cost management.
Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to the drug with the lowest out-of-pocket cost to the patient.
Pharmacy benefit managers and health carriers inclusion of lower-cost drugs in formularies requirement provision and lowest out-of-pocket-cost drug to patient formulary tiering preference provision